In today’s briefing:
- 2025 High Conviction Idea – DIDI Global, Smooth Ride to Higher Profits
- Goldlion Holdings (533 HK): Tsang Family’s Scheme
- Fosun Tourism (1992 HK): Giving In
- HK CEO & Director Dealings (17th Dec 2024): BeiGene, China Wantian, Super Hi Int’l/Haidilao
- Hktv (1137) – Tuesday, Sep 17, 2024
- Lucror Analytics – Morning Views Asia
- Pre-IPO Xunfei Healthcare Technology (PHIP Updates) – Profitability Are Always the Pain Points
2025 High Conviction Idea – DIDI Global, Smooth Ride to Higher Profits
- DiDi Global (DIDI US) has begun to generate positive EBITDA after several challenging years post-IPO. With a high degree of operating leverage, the company is poised to grow quickly.
- Didi which maintains a 70% market share in the ride-hailing industry in China is expanding into Tier 3 cities where there is a large untapped opportunity.
- The company has indicated that it wants to list in Hong Kong in 2025 providing a catalyst for share price re-rating next year.
Goldlion Holdings (533 HK): Tsang Family’s Scheme
- After Goldlion Holdings (533 HK), an apparel manufacturer/distributor, was suspended pursuant to the Takeovers Code, the obvious Offeror, by way of a Scheme, from the Tsang family (63.09% stakeholder).
- And that it’s exactly what unfolded. The Cancellation Price is $1.5232/share (declared final), a 24.85% premium to last price, but a punchy 71% premium to undisturbed.
- The long stop is the 30th September 2025. This will probably be completed in less than half the time. There will be a question mark over the low price-to-book multiple.
Fosun Tourism (1992 HK): Giving In
- It is difficult for Fosun Tourism (1992 HK) to return to its peak and IPO share prices over the next two years. The buyback proposal represents a good exit opportunity.
- Net profit is unlikely to go back to FY19 level even in FY26F. The derating of the Chinese equities and Fosun Group, as well as its high gearing, are barriers.
- Its PER multiples have already aligned back to the sector average from the extremely depressed level previously. Relative to global names, it is now only at slight discounts.
HK CEO & Director Dealings (17th Dec 2024): BeiGene, China Wantian, Super Hi Int’l/Haidilao
- The data in this insight is collated from the “shareholding disclosure” link on the HKEx website.
- Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors. Or pledging. However, such disclosures are by no means an absolute.
- The key stocks mentioned in this regular insight include: BeiGene (6160 HK), China Wantian Holdings (1854 HK), and Super Hi International Holding (9658 HK) / Haidilao International Holding (6862 HK).
Hktv (1137) – Tuesday, Sep 17, 2024
- HKTV is a prominent e-commerce platform in Hong Kong facing challenges from the pandemic and retail market.
- Founder Ricky Wong has shown a history of moonshot diversifications and strong leadership from executives like Jelly Zhou, leading to renewed optimism for the company.
- With a low valuation, potential for growth, and Ricky Wong’s history of successful ventures, HKTV could be a lucrative investment opportunity in the future.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.
Lucror Analytics – Morning Views Asia
- In today’s Morning Views publication we comment on developments of the following high yield issuers: New World Development, Vedanta Resources, Softbank Group, AAC Technologies
- In the US, the December (preliminary) S&P manufacturing PMI fell to 48.3 (49.5 e / 49.7 p), while the services PMI expanded to 58.5 (55.8 e / 56.1 p).
- The composite PMI also rose to 56.6 (55.1 e / 54.9 p). Treasuries were little changed, ahead of the Fed’s rate decision tomorrow. The yield on the 2Y and 10Y UST were flat at 4.25% and 4.40%, respectively.
Pre-IPO Xunfei Healthcare Technology (PHIP Updates) – Profitability Are Always the Pain Points
- Medical industry characteristics are the seriousness of diagnosis/treatment and the irreversibility of the process, which are the difficulties in implementing technology. The value that AI can provide is limited.
- Xunfei’s business model is not To C, but To G (government) model. It’s not possible for SOE customers to pay high price for Xunfei’s AI model/products, leading to questionable profitability.
- Pre-IPO valuation has reached RMB8.4 billion. Without sustainable growth and stable profitability, valuation/liquidity of Xunfei after listing wouldn’t be good. We think Xunfei’s valuation could be similar to Yidu Tech.